[Featured Stock] Wooridul Hu Brain Rises on Collaboration with BBB for COVID-19 Diagnostic Kit
[Asia Economy Reporter Minwoo Lee] Wooridle Hubrain's stock price is on the rise. The diagnostic kit company VVV, a partner of Celltrion, is releasing a new coronavirus disease (COVID-19) diagnostic kit together, and the news that VVV is pursuing the acquisition of management rights of Syswork has highlighted Wooridle Hubrain's stake.
As of 2:15 PM on the 24th, Wooridle Hubrain's stock price was traded at 3,965 KRW, up 8.33% from the previous day. The news that it holds a 10.01% stake in VVV appears to have acted as a positive factor.
VVV, a diagnostic kit company partnered with Celltrion, plans to participate in a paid-in capital increase of 8.334 billion KRW by Syswork on the 4th of next month to acquire management rights. It is expected to achieve a backdoor listing through this.
Hot Picks Today
!["Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"](https://cwcontent.asiae.co.kr/asiaresize/93/2026051507261063923_1778797570.png)
"Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- "I'm No Longer the Center?"... Even the World's Top Sniper Sidelined in the Era of Drones
- Experts Already Watching Closely..."Target Price Set at 970,000 Won" Only Upward Momentum Remains [Weekend Money]
As Wooridle Hubrain is strengthening cooperation by distributing VVV's severe brain disease treatment device 'Neurogear' and jointly developing COVID-19 diagnostic kits, expectations for cooperation among the three companies are growing.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
